Category: Oral Hypoglycemic
Active constituent: Glimepiride
Concentrations: 4 mg                  
Indications: Type II Diabetes mellitus
Dose : Once daily
The effective sulphonylurea with the safest hypoglycemic potential
Promising enhancement in insulin resistance.

Contact Address

UPC 

56 th queen farida st., al miraj city

New maadi

Cairo

Egypt

Phone: +202 26 17 61 85

Fax: +20224470563

Email: upc@egyupc.com

About UPC

UPC is an Egyptian company operating in the pharmaceutical field since 1998
Dr.Yehia Saudi is the company CEO.